- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/19 - InterferonsLymphokinesCytokines
Patent holdings for IPC class C12N 15/19
Total number of patents in this class: 198
10-year publication summary
7
|
2
|
10
|
2
|
10
|
11
|
12
|
7
|
5
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20059 |
5 |
National University Corporation Kanazawa University | 243 |
5 |
Regeneron Pharmaceuticals, Inc. | 4323 |
5 |
Genentech, Inc. | 3994 |
4 |
Chugai Seiyaku Kabushiki Kaisha | 1367 |
4 |
Institute for Research in Biomedicine (IRB) | 39 |
4 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3183 |
4 |
Yale University | 2401 |
4 |
Actym Therapeutics, Inc. | 30 |
4 |
Nissan Chemical Corporation | 2050 |
4 |
Apollo Life Sciences Limited | 10 |
3 |
Knc Laboratories Co., Ltd. | 37 |
3 |
Kyoto University | 2809 |
3 |
OncoMed Pharmaceuticals, Inc. | 77 |
3 |
Sunshine Lake Pharma Co., Ltd. | 599 |
3 |
Warsaw Orthopedic, Inc. | 3012 |
2 |
The Trustees of Columbia University in the City of New York | 3584 |
2 |
Kagoshima University | 309 |
2 |
National University Corporation Kobe University | 531 |
2 |
NGM Biopharmaceuticals, Inc. | 178 |
2 |
Other owners | 130 |